Variant report

Variant	esv3385718
Chromosome Location	chr2:234638378-234656442
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:234653876-234654428	HepG2	liver:	n/a	n/a
2	ATF3	chr2:234653988-234654486	A549	lung:	n/a	n/a
3	BCL3	chr2:234653958-234654499	A549	lung:	n/a	n/a
4	BCL3	chr2:234653885-234654544	A549	lung:	n/a	n/a
5	BHLHE40	chr2:234654058-234654451	HepG2	liver:	n/a	n/a
6	CEBPB	chr2:234645458-234645657	HepG2	liver:	n/a	n/a
7	CEBPB	chr2:234638858-234639186	HepG2	liver:	n/a	chr2:234639027-234639038
8	CEBPB	chr2:234639004-234639011	H1-hESC	embryonic stem cell:	n/a	n/a
9	CEBPB	chr2:234639642-234639778	HepG2	liver:	n/a	n/a
10	CEBPB	chr2:234653961-234654410	HepG2	liver:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
11	CEBPB	chr2:234638863-234639204	IMR90	lung:	n/a	chr2:234639027-234639038
12	CEBPB	chr2:234653908-234654385	HepG2	liver:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
13	CEBPB	chr2:234638876-234639151	K562	blood:	n/a	chr2:234639027-234639038
14	CEBPB	chr2:234653892-234654497	A549	lung:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
15	CEBPB	chr2:234653979-234654335	HepG2	liver:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
16	CEBPB	chr2:234654020-234654389	A549	lung:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
17	CEBPB	chr2:234638962-234639116	Hela-S3	cervix:	n/a	chr2:234639027-234639038
18	CEBPB	chr2:234653902-234654598	HepG2	liver:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
19	CEBPB	chr2:234653943-234654318	A549	lung:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
20	CEBPB	chr2:234638913-234639194	A549	lung:	n/a	chr2:234639027-234639038
21	CEBPD	chr2:234654049-234654478	HepG2	liver:	n/a	n/a
22	CHD2	chr2:234654164-234654273	HepG2	liver:	n/a	n/a
23	CREB1	chr2:234653888-234654608	HepG2	liver:	n/a	n/a
24	CREB1	chr2:234653968-234654547	HepG2	liver:	n/a	n/a
25	CREB1	chr2:234654194-234654509	A549	lung:	n/a	n/a
26	CREB1	chr2:234654062-234654459	A549	lung:	n/a	n/a
27	CTCF	chr2:234651938-234652009	GM20000	blood:	n/a	n/a
28	CTCF	chr2:234638531-234638615	GM10266	blood:	n/a	n/a
29	CTCF	chr2:234641324-234641453	Kidney_OC	kidney:	n/a	n/a
30	CTCF	chr2:234651956-234652041	Kidney_OC	kidney:	n/a	n/a
31	CTCF	chr2:234641321-234641453	GM10248	blood:	n/a	n/a
32	ELF1	chr2:234645668-234646001	HepG2	liver:	n/a	n/a
33	ELF1	chr2:234645669-234646004	HepG2	liver:	n/a	n/a
34	EP300	chr2:234653810-234654542	A549	lung:	n/a	chr2:234654068-234654082 chr2:234653862-234653871
35	EP300	chr2:234654030-234654453	HepG2	liver:	n/a	chr2:234654068-234654082
36	EP300	chr2:234653933-234654548	HepG2	liver:	n/a	chr2:234654068-234654082
37	EP300	chr2:234647009-234647365	HepG2	liver:	n/a	n/a
38	EP300	chr2:234653700-234654700	A549	lung:	n/a	chr2:234654068-234654082 chr2:234653862-234653871
39	EP300	chr2:234653868-234654574	HepG2	liver:	n/a	chr2:234654068-234654082
40	FOSL2	chr2:234654004-234654404	A549	lung:	n/a	n/a
41	FOSL2	chr2:234645566-234646080	HepG2	liver:	n/a	n/a
42	FOSL2	chr2:234653860-234654613	A549	lung:	n/a	n/a
43	FOSL2	chr2:234653946-234654485	HepG2	liver:	n/a	n/a
44	FOSL2	chr2:234654000-234654628	HepG2	liver:	n/a	n/a
45	FOSL2	chr2:234638767-234639039	HepG2	liver:	n/a	chr2:234638889-234638898
46	FOXA1	chr2:234645272-234646144	HepG2	liver:	n/a	n/a
47	FOXA1	chr2:234645291-234646127	HepG2	liver:	n/a	n/a
48	FOXA1	chr2:234645272-234646097	HepG2	liver:	n/a	n/a
49	FOXA1	chr2:234643480-234643864	HepG2	liver:	n/a	n/a
50	FOXA1	chr2:234653906-234654589	HepG2	liver:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:234655709-234655759	MCF10A-Er-Src	breast:	n/a
2	chr2:234652601-234652651	AG09309	skin:	n/a
3	chr2:234651850-234651900	A549	lung:	n/a
4	chr2:234651850-234651900	AG09309	skin:	n/a
5	chr2:234655709-234655759	AG04450	lung:	fetal
6	chr2:234652681-234652731	HCM	heart:	n/a
7	chr2:234655709-234655759	HRPEpiC	eye:	n/a
8	chr2:234652669-234652719	NHBE	bronchial:	n/a
9	chr2:234651850-234651900	GM12891	blood:	n/a
10	chr2:234652681-234652731	CMK	blood:	n/a
11	chr2:234652363-234652413	SKMC	muscle:	n/a
12	chr2:234649204-234649254	CMK	blood:	n/a
13	chr2:234653891-234653941	ECC-1	luminal epithelium:	n/a
14	chr2:234649204-234649254	HL-60	blood:	n/a
15	chr2:234652681-234652731	GM19239	blood:	n/a
16	chr2:234653891-234653941	Jurkat	blood:	n/a
17	chr2:234655709-234655759	SK-N-MC	brain:	n/a
18	chr2:234652363-234652413	HUVEC	blood vessel:	n/a
19	chr2:234652669-234652719	AG09319	gingival:	n/a
20	chr2:234652601-234652651	GM12891	blood:	n/a
21	chr2:234652601-234652651	ECC-1	luminal epithelium:	n/a
22	chr2:234649204-234649254	HepG2	liver:	n/a
23	chr2:234652669-234652719	PFSK-1	brain:	n/a
24	chr2:234649204-234649254	AG09319	gingival:	n/a
25	chr2:234650765-234650815	PrEC	prostate:	n/a
26	chr2:234655709-234655759	HIPEpiC	eye:	n/a
27	chr2:234652466-234652516	Caco-2	colon:	n/a
28	chr2:234653891-234653941	T-47D	breast:	n/a
29	chr2:234652601-234652651	SK-N-MC	brain:	n/a
30	chr2:234652466-234652516	GM12878	blood:	n/a
31	chr2:234650765-234650815	PFSK-1	brain:	n/a
32	chr2:234652466-234652516	HRCEpiC	kidney:	n/a
33	chr2:234652669-234652719	HEEpiC	esophagus:	n/a
34	chr2:234652669-234652719	ProgFib	skin:	n/a
35	chr2:234651850-234651900	BE2_C	brain:	n/a
36	chr2:234652363-234652413	ovcar-3	ovarian:	n/a
37	chr2:234652363-234652413	NHBE	bronchial:	n/a
38	chr2:234652466-234652516	HMEC	breast:	n/a
39	chr2:234653891-234653941	NT2-D1	testis:	n/a
40	chr2:234653891-234653941	Caco-2	colon:	n/a
41	chr2:234653891-234653941	CMK	blood:	n/a
42	chr2:234651850-234651900	HAEpiC	amniotic membrane:	n/a
43	chr2:234652466-234652516	IMR90	lung:	fetal
44	chr2:234651850-234651900	HepG2	liver:	n/a
45	chr2:234652669-234652719	SAEC	small airway:	n/a
46	chr2:234653891-234653941	LNCaP	prostate:	n/a
47	chr2:234652363-234652413	Jurkat	blood:	n/a
48	chr2:234651850-234651900	HPAEpiC	pulmonary alveolar:	n/a
49	chr2:234649204-234649254	PrEC	prostate:	n/a
50	chr2:234652363-234652413	AG04450	lung:	fetal

No.	Distal block	Cell Line	Cell type
1	2:234635414-234639782..2:234772667-234780240	Hela-S3	cervix:
2	chr2:234650134..234652973-chr2:234653062..234655371,2	MCF-7	breast:
3	2:234543708-234558325..2:234649753-234657866	Hela-S3	cervix:
4	chr2:234637896..234640536-chr2:234645854..234647790,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-UGT1A1-2	chr2:234650166-234650603	NONHSAT077507
2	lnc-UGT1A1-2	chr2:234649334-234649521	NONHSAT077507
3	lnc-UGT1A1-2	chr2:234647598-234647701	NONHSAT077507

Variant related genes	Relation type
UGT1A2P	TF binding region
ENSG00000248705	TF binding region
ENSG00000248114	TF binding region
DNAJB3	TF binding region
UGT1A2P	CpG island
ENSG00000248705	CpG island
ENSG00000248114	CpG island
DNAJB3	CpG island
ENSG00000234143	chromatin interactions
ENSG00000248114	chromatin interactions
ENSG00000227802	chromatin interactions
ENSG00000224287	chromatin interactions
ENSG00000242515	chromatin interactions

Extended variants
information (count: 855 )
Associated
traits (count: 63 )

Variant overlapped rSNPs/rCNVs (count:855 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs573582484	chr2:234638388-234638389	Strong transcription Flanking Active TSS Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs140766748	chr2:234638394-234638395	Strong transcription Flanking Active TSS Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs559236569	chr2:234638414-234638415	Strong transcription Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs139850391	chr2:234638422-234638423	Strong transcription Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs377448970	chr2:234638434-234638435	Strong transcription Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs370250320	chr2:234638438-234638439	Strong transcription Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs145403444	chr2:234638439-234638440	Strong transcription Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs45547931	chr2:234638448-234638449	Strong transcription Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs61740163	chr2:234638451-234638452	Strong transcription Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs530955113	chr2:234638481-234638482	Strong transcription Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs146461519	chr2:234638508-234638509	Strong transcription Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs567615944	chr2:234638510-234638511	Strong transcription Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs115983652	chr2:234638522-234638523	Strong transcription Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs149324549	chr2:234638547-234638548	Strong transcription Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs28898620	chr2:234638554-234638555	Strong transcription Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs138129589	chr2:234638555-234638556	Strong transcription Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs530125998	chr2:234638576-234638577	Strong transcription Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs45449995	chr2:234638580-234638581	Strong transcription Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs371021401	chr2:234638599-234638600	Strong transcription Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs149856651	chr2:234638611-234638612	Strong transcription Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs201755757	chr2:234638614-234638615	Strong transcription Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs201645683	chr2:234638622-234638623	Strong transcription Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs559233241	chr2:234638644-234638645	Strong transcription Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs569428615	chr2:234638646-234638647	Strong transcription Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs372957768	chr2:234638647-234638648	Strong transcription Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs45599733	chr2:234638681-234638682	Strong transcription Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs201527388	chr2:234638684-234638685	Strong transcription Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs2361501	chr2:234638690-234638691	Strong transcription Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs115693071	chr2:234638721-234638722	Strong transcription Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs45462400	chr2:234638780-234638781	Strong transcription Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs546399055	chr2:234638806-234638807	Strong transcription Transcr. at gene 5' and 3' Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs556230722	chr2:234638810-234638811	Strong transcription Transcr. at gene 5' and 3' Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs142374428	chr2:234638811-234638812	Strong transcription Transcr. at gene 5' and 3' Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs45486905	chr2:234638818-234638819	Strong transcription Transcr. at gene 5' and 3' Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs544900257	chr2:234638844-234638845	Strong transcription Transcr. at gene 5' and 3' Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs186476397	chr2:234638857-234638858	Strong transcription Transcr. at gene 5' and 3' Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs144120008	chr2:234638869-234638870	Strong transcription Transcr. at gene 5' and 3' Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs544044923	chr2:234638882-234638883	Strong transcription Transcr. at gene 5' and 3' Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs45449797	chr2:234638909-234638910	Strong transcription Transcr. at gene 5' and 3' Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs547052963	chr2:234638911-234638912	Strong transcription Transcr. at gene 5' and 3' Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs566860864	chr2:234638927-234638928	Strong transcription Transcr. at gene 5' and 3' Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs532901219	chr2:234638971-234638972	Strong transcription Transcr. at gene 5' and 3' Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs552905312	chr2:234638982-234638983	Strong transcription Transcr. at gene 5' and 3' Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs190569786	chr2:234638998-234638999	Strong transcription Transcr. at gene 5' and 3' Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs371215104	chr2:234639045-234639046	Weak transcription Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs538447912	chr2:234639052-234639053	Weak transcription Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs554835219	chr2:234639098-234639099	Weak transcription Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs181516968	chr2:234639134-234639135	Weak transcription Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs45560734	chr2:234639168-234639169	Weak transcription Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs28898621	chr2:234639211-234639212	Weak transcription Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:63)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Ependymoma	16718352	CNVD
Melanoma	18172304	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	17603634	CNVD
Breast cancer	16272173	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
Colorectal cancer	16272173	CNVD
Lung cancer	18438408	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	20016488	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Urothelial carcinoma	21177765	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cervical cancer	21062161	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Chordoma	18071362	CNVD
Developmental delay	21147756	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Cancer	22429812	CNVD
Bladder cancer	21909424	CNVD
Renal cell carcinoma	21668985	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
prenatal diagnosis	22389664	CNVD
Myelofibrosis	22110671	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Mental retardation	20152051	CNVD
Cancer	21183584	CNVD
Albright''s disease	22277900	CNVD
Brachydactyly-Mental Retardation Syndrome	22470819	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Colorectal cancer	19359472	CNVD
Autism	18414403	CNVD
Chronic myeloid leukemia	21384125	CNVD
Pancreatic cancer	17952125	CNVD
Congenital anomalies of the kidney and urinary tract	20605837	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:78 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:234620400-234659200	Weak transcription	Colonic Mucosa	Colon
2	chr2:234620600-234652200	Weak transcription	Esophagus	oesophagus
3	chr2:234626200-234649600	Weak transcription	Rectal Mucosa Donor 29	rectum
4	chr2:234626600-234668400	Weak transcription	NHEK	skin
5	chr2:234634600-234639400	Strong transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
6	chr2:234634600-234648400	Weak transcription	A549	lung
7	chr2:234636000-234639000	Strong transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
8	chr2:234636200-234638400	Enhancers	Fetal Intestine Small	intestine
9	chr2:234637800-234638600	Flanking Active TSS	Liver	Liver
10	chr2:234638400-234640200	Weak transcription	Fetal Intestine Small	intestine
11	chr2:234638600-234638800	Active TSS	Liver	Liver
12	chr2:234638800-234639400	Transcr. at gene 5' and 3'	Liver	Liver
13	chr2:234639000-234645600	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
14	chr2:234639400-234639600	Active TSS	Liver	Liver
15	chr2:234639400-234645800	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
16	chr2:234639600-234641000	Weak transcription	Liver	Liver
17	chr2:234641000-234641600	Enhancers	Liver	Liver
18	chr2:234641600-234642400	Weak transcription	Liver	Liver
19	chr2:234642400-234645000	Enhancers	Liver	Liver
20	chr2:234643400-234645000	Enhancers	HepG2	liver
21	chr2:234644000-234645000	Weak transcription	Fetal Intestine Small	intestine
22	chr2:234645000-234645400	Flanking Active TSS	Liver	Liver
23	chr2:234645000-234646200	Enhancers	Fetal Intestine Small	intestine
24	chr2:234645000-234646200	Flanking Active TSS	HepG2	liver
25	chr2:234645400-234648600	Enhancers	Liver	Liver
26	chr2:234645600-234646400	Strong transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
27	chr2:234645600-234647000	Enhancers	Duodenum Mucosa	Duodenum
28	chr2:234645800-234646200	Strong transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
29	chr2:234646200-234646400	Enhancers	Stomach Mucosa	stomach
30	chr2:234646200-234646400	Flanking Bivalent TSS/Enh	HepG2	liver
31	chr2:234646200-234648000	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
32	chr2:234646400-234648800	Bivalent Enhancer	HepG2	liver
33	chr2:234646400-234651000	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
34	chr2:234646400-234666600	Weak transcription	Stomach Mucosa	stomach
35	chr2:234647000-234648000	Weak transcription	Duodenum Mucosa	Duodenum
36	chr2:234647000-234648400	Enhancers	Fetal Intestine Large	intestine
37	chr2:234647600-234647800	Enhancers	Gastric	stomach
38	chr2:234647800-234652200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
39	chr2:234647800-234655000	Weak transcription	Gastric	stomach
40	chr2:234648000-234648600	Enhancers	Duodenum Mucosa	Duodenum
41	chr2:234648000-234649800	Strong transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
42	chr2:234648400-234648600	Enhancers	A549	lung
43	chr2:234648600-234649200	Weak transcription	Duodenum Mucosa	Duodenum
44	chr2:234648600-234649200	Weak transcription	A549	lung
45	chr2:234648600-234650400	Weak transcription	Liver	Liver
46	chr2:234649600-234649800	Enhancers	Rectal Mucosa Donor 29	rectum
47	chr2:234649800-234652200	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
48	chr2:234649800-234658800	Weak transcription	Rectal Mucosa Donor 29	rectum
49	chr2:234650400-234652600	Genic enhancers	Liver	Liver
50	chr2:234651000-234652800	Strong transcription	Foreskin Keratinocyte Primary Cells skin02	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links